Ana Sofia Valério Bolas

Dr. Ana Sofia Valério Bolas

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
Maria Aires PereiraMaria Aires Pereira
Maria Aires Pereira
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
CMCátia Marques
Cátia Marques
GAGraca Alexandre-Pires
Graca Alexandre-Pires
IFIsabel Fonseca Pereira da Fonseca
Isabel Fonseca Pereira da Fonseca
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
Immune system recognize and fight back foreign microorganisms and inner modifications that lead to deficient cell and tissue functions. During a dog’s life, the immune system needs to adapt to different physiological conditions, assuring surveillance and protection in a careful and controlled way. Pregnancy alters normal homeostasis, requiring a balance between immunity and tolerance. The embryos and fetus should be protected from infections, while the female dog must tolerate the growing of semi-allografts in her uterus. After birth, newborn puppies are at great risk of developing infectious diseases, because their immune system is in development and immune memory is absent. Passive transfer of immunity through colostrum is fundamental for puppy survival in the first weeks of life, but hampers the development of an active immune response to vaccination. At the end of life, dogs experience a decline in the structure and functional competence of the immune system, compromising the immune responses to novel antigenic challenges, such as infections and vaccines. Therefore, the current article reviews the general processes related to the development of the dog´s immune system, providing an overview of immune activity throughout the dog’s life and its implications in canine health, and highlighting priority research goals.

1 December 2019 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
DGDra. Áurea Linhares Martins Gabriel
Dra. Áurea Linhares Martins Gabriel
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
JPJoana Palma-Marques
Joana Palma-Marques
PMPatrícia Mourata-Gonçalves
Patrícia Mourata-Gonçalves
PRPedro Ruas
Pedro Ruas
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
This review is aimed at providing a comprehensive outline of the immune response displayed against cutaneous leishmaniasis (CL), the more common zoonotic infection caused by protozoan parasites of the genusLeishmania.Although of polymorphic clinical presentation, classically CL is characterized by leishmaniotic lesions on the face and extremities of the patients, which can be ulcerative, and even after healing can lead to permanent injuries and disfigurement, affecting significantly their psychological, social, and economic well-being. According a report released by the World Health Organization, the disability-adjusted life years (DALYs) lost due to leishmaniasis are close to 2.4 million, annually there are 1.0–1.5 million new cases of CL, and a numerous population is at risk in the endemic areas. Despite its increasing worldwide incidence, it is one of the so-called neglected tropical diseases. Furthermore, this review provides an overview of the existing knowledge of the host innate and acquired immune response to cutaneous species ofLeishmania.The use of animal models and ofin vitrostudies has improved the understanding of parasite-host interplay and the complexity of immune mechanisms involved. The importance of diagnosis accuracy associated with effective patient management in CL reduction is highlighted. However, the multiple factors involved in CL epizoology associated with the unavailability of vaccines or drugs to prevent infection make difficult to formulate an effective strategy for CL control.

1 January 2016 in Journal of Feline Medicine and Surgery Open Reports
Verified
Journal Article
Open access
MBMaria Alexandra Basso
Maria Alexandra Basso
CMCátia Marques
Cátia Marques
MSMarcos Santos
Marcos Santos
ADAna Duarte
Ana Duarte
HPHugo Pissarra
Hugo Pissarra
IFIsabel Fonseca Pereira da Fonseca
Isabel Fonseca Pereira da Fonseca
This work describes the diagnosis and successful treatment of a 2-year-old domestic cat infected with Leishmania species and presenting fever, and ulcerative and nodular skin lesions after being treated for pyodermatitis for 1 year without clinical improvement. After anamnesis the cat was submitted to a complete clinical examination. Blood was collected for determination of haematological and biochemical parameters, detection of feline leukaemia virus (FeLV), feline immunodeficiency virus (FIV), feline coronavirus (FCoV) and Leishmania amastigotes. Fine-needle aspiration puncture from the skin nodules was also performed. After definitive diagnosis the animal was treated and followed up over a 2 year period. The animal tested negative for FIV-specific antibodies, FeLV antigen and feline coronavirus RNA. Leishmania amastigotes in the skin nodules were confirmed by cytology and molecular diagnosis. Treatment was initiated with allopurinol, resulting in a slight clinical improvement. Thus, N-methyl-glucamine antimoniate was added and administered for 30 days, with complete closure of the ulcerative lesions in the hindlimbs requiring a surgical approach. Close monitoring of the patient in the following 24 months indicated that combined therapy was safe and clinical cure was achieved without further relapses or side effects. Considering the increasing number of feline leishmaniosis cases and the inconsistent results of most therapeutic protocols described in the literature, the use of new approaches, especially in refractory cases, is essential. Although the use of allopurinol and N-methyl-glucamine antimoniate is off-label in cats, in this case the combination treatment was followed by an extensive analytical monitoring, supporting their safety and effectiveness.

7 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
JWJuliana Inês Weber
Juliana Inês Weber
Maria Armanda RodriguesMaria Armanda Rodrigues
Maria Armanda Rodrigues
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
TNTelmo Nunes
Telmo Nunes
MCManuela Carvalheiro
Manuela Carvalheiro
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
Leishmaniasis is a parasitic disease caused by different species of Leishmania and transmitted through the bite of sand flies vector. Macrophages (MΦ), the target cells of Leishmania parasites, are phagocytes that play a crucial role in the innate immune microbial defense and are antigen-presenting cells driving the activation of the acquired immune response. Exploring parasite–host communication may be key in restraining parasite dissemination in the host. Extracellular vesicles (EVs) constitute a group of heterogenous cell-derived membranous structures, naturally produced by all cells and with immunomodulatory potential over target cells. This study examined the immunogenic potential of EVs shed by L. shawi and L. guyanensis in MΦ activation by analyzing the dynamics of major histocompatibility complex (MHC), innate immune receptors, and cytokine generation. L. shawi and L. guyanensis EVs were incorporated by MΦ and modulated innate immune receptors, indicating that EVs cargo can be recognized by MΦ sensors. Moreover, EVs induced MΦ to generate a mix of pro- and anti-inflammatory cytokines and favored the expression of MHCI molecules, suggesting that EVs antigens can be present to T cells, activating the acquired immune response of the host. Since nano-sized vesicles can be used as vehicles of immune mediators or immunomodulatory drugs, parasitic EVs can be exploited by bioengineering approaches for the development of efficient prophylactic or therapeutic tools for leishmaniasis.

1 December 2017 in Veterinary Parasitology
Verified
Journal Article
Closed access
Maria Aires PereiraMaria Aires Pereira
Maria Aires Pereira
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
DSDavid Santos-Mateus
David Santos-Mateus
GAGraca Alexandre-Pires
Graca Alexandre-Pires
MSMarcos Santos
Marcos Santos
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes

3 March 2024 in Cells
Verified
Journal Article
Open access
PDF file
ABAna Sofia Valério Bolas
Ana Sofia Valério Bolas
MMMafalda Meunier
Mafalda Meunier
JPJoana Palma-Marques
Joana Palma-Marques
Maria Armanda RodriguesMaria Armanda Rodrigues
Maria Armanda Rodrigues
ASAna Margarida Santos
Ana Margarida Santos
Gabriela Santos-GomesGabriela Santos-Gomes
Gabriela Santos-Gomes
Dendritic cells (DCs) capture pathogens and process antigens, playing a crucial role in activating naïve T cells, bridging the gap between innate and acquired immunity. However, little is known about DC activation when facing Leishmania parasites. Thus, this study investigates in vitro activity of canine peripheral blood-derived DCs (moDCs) exposed to L. infantum and L. amazonensis parasites and their extracellular vesicles (EVs). L. infantum increased toll-like receptor 4 gene expression in synergy with nuclear factor κB activation and the generation of pro-inflammatory cytokines. This parasite also induced the expression of class II molecules of major histocompatibility complex (MHC) and upregulated co-stimulatory molecule CD86, which, together with the release of chemokine CXCL16, can attract and help in T lymphocyte activation. In contrast, L. amazonensis induced moDCs to generate a mix of pro- and anti-inflammatory cytokines, indicating that this parasite can establish a different immune relationship with DCs. EVs promoted moDCs to express class I MHC associated with the upregulation of co-stimulatory molecules and the release of CXCL16, suggesting that EVs can modulate moDCs to attract cytotoxic CD8+ T cells. Thus, these parasites and their EVs can shape DC activation. A detailed understanding of DC activation may open new avenues for the development of advanced leishmaniasis control strategies.